.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Chinese Patent Office
McKinsey
Johnson and Johnson
Deloitte
Fish and Richardson
Boehringer Ingelheim
Fuji
Federal Trade Commission

Generated: December 14, 2017

DrugPatentWatch Database Preview

CLEOCIN T Drug Profile

« Back to Dashboard

When do Cleocin T patents expire, and what generic alternatives are available?

Cleocin T is a drug marketed by Pharmacia And Upjohn and is included in four NDAs.

The generic ingredient in CLEOCIN T is clindamycin phosphate. There are fifty-three drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Pharmacia And UpjohnCLEOCIN Tclindamycin phosphateGEL;TOPICAL050615-001Jan 7, 1987ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCLEOCIN Tclindamycin phosphateSOLUTION;TOPICAL050537-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCLEOCIN Tclindamycin phosphateLOTION;TOPICAL050600-001May 31, 1989ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCLEOCIN Tclindamycin phosphateSOLUTION;TOPICAL062363-001Feb 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Farmers Insurance
Federal Trade Commission
Chubb
Boehringer Ingelheim
UBS
Fuji
Julphar
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot